Speakers

Top Speakers Across 5 Co-Located Conferences

Plenary Speakers

Judith Li
Partner, Lilly Asia Ventures, Hong Kong

Feng Tao
Founding Partner, Biotrack Capital, China

He Ting
Chief Executive Officer, ImmunoChina, China

Dong Wei
CEO, Edigene, China

Jonathan Zhao
PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Peter Luo
CEO, Adagene Pharma, China

Dr Jerry Dong
Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

10th Annual BioSimilars Asia Speakers

Dr Wu Youling
Chief Executive Officer, ZheJiang Teruisi Biopharmaceutical, China

Dr. Manfred Weiler
Senior Vice President, Medical & Scientific Strategy, Syneos Health, UK

Dr Lin Shiwen
Vice President of Downstream Process Development, WuXi Biologics, China

Dr Zou Linglong
Executive Director, Head of Bioanalytics, Shanghai Henlius Biotech, China

Frank Ye
Senior Vice President, Technical Operations, Hangzhou JUST Biotherapeutics, China

Dr Dennis Lin
Supervisor, Upstream Process Development, Mycenax Biotech Inc, Taiwan

Asif Mahmood
Disease Area Cluster Lead, Pfizer, USA

Dr Peter Pang
General Manager, XiKang (Wuhan) Biopharmaceutical Co.Ltd., EVP, Corporate Head of Regulatory Affairs, JHL Biotech Inc, China

Sumimasa Nagai
Deputy Director of the Translational Research Centre / Clinical Expert Advisor at the Office of New Drug V (Oncology) and Companion Diagnostics Working Group, University of Tokyo Hospital / Pharmaceuticals and Medical Devices Agency, Japan

Dr Jiang Weidong
Vice President and Chief Scientific Officer, Shanghai Henlius Biotech, China

Wang Yongzhong
President of Pharmaceuticals, Executive Vice President, Simcere Pharmaceutical Group, China

9th Annual Biomanufacturing Speakers

Dr Junli Zhang
Senior Vice President & Chief Operating Officer, Shanghai Henlius Biotech, Inc.

Jason Lukasek
Senior Director, BEA, BPD Commercial, Thermo Fisher Scientific

Dr. Jimmy Li
Vice President & Head of Manufacturing Facility 1 of Wuxi Site, Wuxi Biologics, China

Dr. Xiangyang Zhu
Chief Executive Officer, Huabo Biopharma, China

Dr Peter Pang
General Manager, XiKang (Wuhan) Biopharmaceutical Co.Ltd., EVP, Corporate Head of Regulatory Affairs, JHL Biotech Inc, China

Dr. Jerry Yang
Senior Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd. China

David Johnson
Senior Global Product Manager, Pall Biotech

Liu Changjun
Product Manager, GE

Dr. Qinghai Zhao
Vice President, Technical Development & Manufacturing, Forty Seven, Inc., U.S.

Wenzhi Tian
MD, Chairman & CEO, ImmuneOnco Biopharma Co., Ltd, China

Dr Jerry Dong
Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

Dr Zack Zheng
Vice President of Manufacturing and Technology, JHL Biotech, China

Rhona McIntyre
Associate Director Commercial Development, Lonza Pharma & Biotech

Michelle Peake
Senior General Manager, PT Kalbio Global Medika, Indonesia

David Jan
SVP Manufacturing Operations, Zhejiang Teruisi Biopharmaceutical, China

John K. Kawooya
Director, Biologics Optimization, Amgen, Inc.

Dr. Lin Yang
Chief Executive Officer, PersonGen Biomedicine, China

8th Annual Cell Line Development and Engineering Asia Speakers

George Hutchinson
Head of Global Distribution, Solentim, UK

Thomas Kelly
Scientist, Cell & Developability Sciences, Pharmaceutical Development & Manufacturing Sciences (PDMS), Janssen R&D, U.S.

Dr. John Yan
Applications Scientist, ProZyme, U.S.

Dr. Senyon Choe (Teddy)
Professor, Biology, University of California San Diego (UCSD), U.S. and President and Director of Joint Center for Biosciences, South Korea

Dr. Carolanne Doherty
Marketing & Sales Manager, Valitacell, Ireland

Dr. Ben Borgo
Associate Director, Assays, Reagents, and Software, Berkeley Lights, U.S.

Dong-Yup Lee
Associate Professor, College of Engineering, Sung Kyun Kwan University (SKKU), South Korea

Dr. Steve Oh
Institute Scientist and Director, Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR, Singapore

Ben Werdelmann
Director, Business Development and Applications, SYNENTEC GmbH, Germany

Fabian Stumpf
CMO, Cytena, Germany

Dr. Qinghai Zhao
Vice President, Technical Development & Manufacturing, Forty Seven, Inc., U.S.

Dr. Jerry Yang
SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Cuiyun Xu
Director, Upstream Process Development, Shanghai Henlius Biotech, Inc., China

Eric Chang
Head of Cell Line Development, JHL Biotech, Taiwan

4th Annual Clinical Trials Speakers

Dr. Xin Zhang
Vice President of Global Clinical Operations and Affairs, Shanghai Henlius Biotech, Inc., China

Ting He
Chief Executive Officer, ImmunoChina, China

Hei Yongjiang
Chief Medical Officer, Oncology, Zai Laboratory, China

Jennifer Harmon
Director, Clinical Affairs, SynAgile, Singapore

Dr. Alvin Luk
Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Joanne Chio
Head, Clinical Trials – Healthcare Services, National University Hospital Singapore, Singapore

Xiaorui Wang
VP of Regulatory Affairs & Clinical Development Zensun, China

Dr Jean-Louis Excler
Head of Clinical Development & Regulatory, International Vaccine Institute, Korea

Eddy Wu
China Head/Vice-President, Terns Pharmaceutical, China

James Cheng-Chung Wei
Professor, Institute of Medicine, Chief, Division of Allergy, Immunology and Rheumatology, Director, Chinese Medicine Clinical Trial Center, Chung Shan Medical University Hospital, Taiwan

Rong Chen
Chief Medical Officer, JHL Biotech, China

Cell and Gene Therapy Speakers

Judith Li
Partner, Lilly Asia Ventures, Hong Kong

Chelsea Zhang
Partner, Ping An Ventures, China

Amy Tang
Venture Partner, Healthcare, Qiming Venture Partners, China

Dr. Kevin Li
Managing Partner, LYZZ Capital Advisors, China

Shuyuan Yao
General Manager, Wuxi ATU Co., Ltd., China

Dody Bautista
Chief Scientist, Sibiono GeneTech, China

Jieyu Zou
Vice President, Lilly Asia Ventures, China

Jun Wang
Marketing Manager, PALL® Biotech, China

Dr. Alvin Luk
Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Shuyuan Yao
General Manager, Wuxi ATU Co., Ltd., China

Jiansong Tong
Director and Head of CAR-T Cell Therapy, Shanghai Hengrui Pharmaceutical, China

Daniel Takefman
Head of Regulatory Affairs, Spark Therapeutics, United States

Chen-Yuan Lin
Ward Director and Attending Physician at the Division of Hematology and Oncology, China Medical University Hospital, Taiwan

Steve Oh
Institute Professor and Scientist at the Bioprocessing Technology Institute, A-STAR, Singapore

Sandy Qlintang
Deputy Director of Stem Cell and Cancer Institute, PT Kalbe Farma, Indonesia

Morakot Papassiripan
Pharmacist at the Professional Level at the Biological Sub-Division, Bureau of Drug Control, Food and Drug Administration of Thailand, Thailand

David Bekkers
Officer for Innovation, Technology & Science, Holland Innovation Network in China, Netherlands

Richard Wang
CEO, Fosun Kite Biotech, China

Sumimasa Nagai
Deputy Director of the Translational Research Centre / Clinical Expert Advisor at the Office of New Drug V (Oncology) and Companion Diagnostics Working Group, University of Tokyo Hospital / Pharmaceuticals and Medical Devices Agency, Japan

Paolo Morgese
Director for EU Market Access and Member Relations, Alliance for Regenerative Medicine, Switzerland